Bonus BioGroup Statistics

Total Valuation

Bonus BioGroup has a market cap or net worth of ILS 137.82 million. The enterprise value is 134.39 million.

Market Cap	137.82M
Enterprise Value	134.39M

Important Dates

The next estimated earnings date is Thursday, November 28, 2024.

Earnings Date	Nov 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Bonus BioGroup has 1.17 billion shares outstanding.

Current Share Class	n/a
Shares Outstanding	1.17B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	57.27%
Owned by Institutions (%)	0.02%
Float	499.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.60
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.69

Financial Position

The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.70.

Current Ratio	1.95
Quick Ratio	1.95
Debt / Equity	0.70
Debt / EBITDA	n/a
Debt / FCF	-0.45
Interest Coverage	-37.25

Financial Efficiency

Return on equity (ROE) is -99.82% and return on invested capital (ROIC) is -46.01%.

Return on Equity (ROE)	-99.82%
Return on Assets (ROA)	-40.88%
Return on Capital (ROIC)	-46.01%
Revenue Per Employee	n/a
Profits Per Employee	-503,276
Employee Count	58
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.95% in the last 52 weeks. The beta is 1.02, so Bonus BioGroup's price volatility has been similar to the market average.

Beta (5Y)	1.02
52-Week Price Change	-20.95%
50-Day Moving Average	12.50
200-Day Moving Average	16.18
Relative Strength Index (RSI)	38.94
Average Volume (20 Days)	1,031,532

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.77M
Pretax Income	-29.19M
Net Income	-29.19M
EBITDA	-28.09M
EBIT	-29.77M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 14.14 million in cash and 10.72 million in debt, giving a net cash position of 3.42 million or 0.00 per share.

Cash & Cash Equivalents	14.14M
Total Debt	10.72M
Net Cash	3.42M
Net Cash Per Share	0.00
Equity (Book Value)	15.40M
Book Value Per Share	n/a
Working Capital	7.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -23.16 million and capital expenditures -464,000, giving a free cash flow of -23.62 million.

Operating Cash Flow	-23.16M
Capital Expenditures	-464,000
Free Cash Flow	-23.62M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bonus BioGroup does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a